HomeCare Guidelines
Care Guidelines
Care Guidelines
Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD
Duchenne muscular dystrophy speech delay is an important developmental concern that families and healthcare professionals should recognize. Although Duchenne muscular dystrophy (DMD) is primarily known as a genetic neuromuscular condition causing progressive muscle weakness, research has shown that some boys with DMD can also experience differences or delays in...
Care Guidelines
Guide to DMD for Parents and Teachers at School: A Complete Guide for Safety, Learning, Friendship and Inclusion
A well-structured guide to DMD for parents and teachers at school is essential for supporting children with Duchenne Muscular Dystrophy (DMD) in educational environments. DMD is a progressive neuromuscular condition that affects muscle strength, endurance, and sometimes cognitive functioning. These challenges directly influence how a child participates in school...
Keep exploring
Care Guidelines
Ultimate Age-Specific Care Considerations in Duchenne Muscular Dystrophy for Families and Clinicians
Age-Specific care considerations in Duchenne muscular dystrophy are central to optimizing outcomes in individuals...
Care Guidelines
Best Physical Therapy Strategies for Duchenne Muscular Dystrophy
Physical therapy in Duchenne muscular dystrophy (DMD) is a cornerstone of comprehensive disease management,...
Care Guidelines
Occupational Therapy in Duchenne Muscular Dystrophy: Complete Guide to DMD Rehabilitation
Occupational therapy in Duchenne muscular dystrophy (DMD) plays a critical role in preserving independence,...
Care Guidelines
Hydrotherapy in Duchenne Muscular Dystrophy (DMD): Benefits, Exercises, and Clinical Evidence
Hydrotherapy in Duchenne Muscular Dystrophy (DMD)—also known as aquatic therapy, water-based rehabilitation, or pool-based...
Care Guidelines
Newly Diagnosed Patients with Duchenne Muscular Dystrophy: A Complete Family Guide
Newly diagnosed patients with Duchenne muscular dystrophy (DMD) and their families often find themselves...
Care Guidelines
Scoliosis in Duchenne Muscular Dystrophy: Detection, Exercises, and Surgical Treatment
Scoliosis in Duchenne Muscular Dystrophy is one of the most significant orthopedic complications associated...
Care Guidelines
Orton-Gillingham Approach in Duchenne Muscular Dystrophy: Benefits, Evidence & Applications
The Orton-Gillingham approach in Duchenne muscular dystrophy is gaining attention as families and clinicians...
Care Guidelines
Stress and Anxiety in Duchenne Muscular Dystrophy: Symptoms, Support & Treatment
Stress and anxiety in Duchenne muscular dystrophy (DMD) are increasingly recognized as critical yet...
Care Guidelines
Essential Knowledge About Learning Disabilities in Duchenne Muscular Dystrophy
Learning disabilities in Duchenne muscular dystrophy represent a critical yet often overlooked aspect of...
Care Guidelines
Managing Bone Fractures in Duchenne Muscular Dystrophy (DMD): Prevention, Risks & Treatment
Managing Bone Fractures in Duchenne muscular dystrophy (DMD) is a critical component of multidisciplinary...
Care Guidelines
Emergency Care in Duchenne Muscular Dystrophy: Life-Saving Strategies, Risks, and Clinical Guidelines
Emergency care in Duchenne muscular dystrophy (DMD) is a critical and often life-saving aspect...
Care Guidelines
Heart Health in Duchenne Muscular Dystrophy: Cardiomyopathy, Detection, and Modern Treatment Strategies
Heart health in Duchenne Muscular Dystrophy is a critical yet often underrecognized aspect of...
Latest articles
Press Releases
Entrada Therapeutics ENTR-601-45: Early Exon 45 Skipping Study Shows Increased Dystrophin Production
Entrada Therapeutics has announced positive initial results from its Exon 45 Skipping Study, ELEVATE-45-201,...
Press Releases
Entrada Therapeutics Advances ENTR-601-44 to 18 mg/kg in Its Duchenne Exon 44 Skipping Study
Entrada Therapeutics has received clearance to test the highest dose in its Exon 44...
Research
Sapreme Therapeutics Reports Strong Preclinical Dystrophin Restoration With SPM-2551 in Duchenne
Sapreme Therapeutics has announced promising preclinical results for SPM-2551, an experimental treatment for Duchenne...
Press Releases
Deramiocel Shows Positive 24-Month HOPE-3 Results in Duchenne
Capricor Therapeutics has reported new results from the HOPE-3 study evaluating Deramiocel in people...
Press Releases
Ractigen Therapeutics Reports Positive First-in-Human Data for RAG-18 in Duchenne
Ractigen Therapeutics has presented positive first-in-human data for RAG-18 (NCT07282652), an investigational treatment for...
Press Releases
Entrada Therapeutics’ ENTR-601-44 Shows Dose-Dependent Exon 44 Skipping in Early PK/PD Data
Entrada Therapeutics’ ENTR-601-44 is an investigational therapy designed for patients with Duchenne muscular dystrophy...
Press Releases
NS Pharma’s Brogidirsen Shows 5-Year Clinical Data in DMD Patients Amenable to Exon 44 Skipping
NS Pharma’s brogidirsen (NS-089/NCNP-02) is an investigational therapy for Duchenne muscular dystrophy (DMD) designed...
Press Releases
ELEVIDYS WMS 2026 Data: What They Show—and What They Don’t
Sarepta Therapeutics has presented new data on ELEVIDYS (delandistrogene moxeparvovec) at the 2026 World...
